Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Tuberous Sclerosis × Vigabatrin × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Neoplasms 1 Epilepsy 1

Interventions

Sirolimus 2 Everolimus 2 Vigabatrin 1 Fluid Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04987463 2024-02-08

ViRap

Children's Memorial Health Institute, Poland

Phase 2/3 Recruiting

Epilepsy, Neoplasms, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡